Crystal Bioscience and Genexis Complete Selection of 'FindingBio' First Cohort

[Asia Economy Reporter Lee Chun-hee] Crystal Bioscience and Genexis announced on the 19th that they have selected six companies through the bio-healthcare startup program ‘Finding BIO.’ Finding BIO is a program that discovers promising startups in the bio-healthcare industry and provides focused nurturing and investment. It is the first project jointly operated by CBS and Genexis.

In the first cohort, over 130 startups applied, and a total of six companies were finally selected: two in digital healthcare, two in new drugs and diagnostics, one in pet health, and one in regenerative medicine. The selected companies are ▲Dolbom Dream (HUGgy, an AI-based smart care vest that helps psychological stability) ▲Inhand Plus (AI smartwatch-based digital medication management solution) ▲Ropel Bio (PD-L1 combination biomarker technology utilizing the characteristics of DRG2, a key component of the PD-L1 recycle mechanism) ▲Twin Pig Bio Lab (development of peptide new drugs that target TAM (tumor-associated macrophage) to regulate the tumor microenvironment and enhance the efficacy of anticancer drugs) ▲H-Flex (pet self-diagnosis service and health management solution platform), and ▲Medicos Biotech (tissue regeneration and anti-aging solutions using spider silk protein and growth factors).

Going forward, various benefits will be provided, including direct investment of up to 1 billion KRW per company for outstanding graduates, IR consulting, expert mentoring on research and development/business planning and execution, customized mentoring according to new drug development cycles, ▲utilization of CBS affiliate infrastructure and employee mentoring, and ▲support for follow-up investment attraction using demo days and domestic and international operator networks.

Son Mi-kyung, CEO of Genexis, said, “Based on our experience operating government projects and various accelerating (startup planning) programs, we plan to support the early startups selected in the first Finding BIO cohort to achieve solid growth.”

This content was produced with the assistance of AI translation services.